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Original Article
Objectives: We compared the associations of 3 computed tomography (CT)-based abdominal adiposity indexes with non-alcoholic 
fatty liver disease (NAFLD) among middle-aged Korean men and women.
Methods: The participants were 1366 men and 2480 women community-dwellers aged 30-64 years. Three abdominal adiposity in-
dexes—visceral fat area (VFA), subcutaneous fat area (SFA), and visceral-to-subcutaneous fat ratio (VSR)—were calculated from ab-
dominal CT scans. NAFLD was determined by calculating the Liver Fat Score from comorbidities and blood tests. An NAFLD prediction 
model that included waist circumference (WC) as a measure of abdominal adiposity was designated as the base model, to which VFA, 
SFA, and VSR were added in turn. The area under the receiver operating characteristic curve (AUC), integrated discrimination improve-
ment (IDI), and net reclassification improvement (NRI) were calculated to quantify the additional predictive value of VFA, SFA, and VSR 
relative to WC.
Results: VFA and VSR were positively associated with NAFLD in both genders. SFA was not significantly associated with NAFLD in men, 
but it was negatively associated in women. When VFA, SFA, and VSR were added to the WC-based NAFLD prediction model, the AUC 
improved by 0.013 (p<0.001), 0.001 (p=0.434), and 0.009 (p=0.007) in men and by 0.044 (p<0.001), 0.017 (p<0.001), and 0.046 
(p<0.001) in women, respectively. The IDI and NRI were increased the most by VFA in men and VSR in women.
Conclusions: Using CT-based abdominal adiposity indexes in addition to WC may improve the detection of NAFLD. The best predic-
tive indicators were VFA in men and VSR in women.
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INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is an increasingly 
common liver disease with an estimated prevalence of 20-30% 
[1]. NAFLD can increase the risk of overall and liver-related mor-
tality and is also considered a feature of cardiometabolic syn-
drome [2]. Thus, the early detection of NAFLD and the identifi-
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cation of people at risk of developing the disease are impor-
tant public health issues.
The quantity of abdominal fat is closely associated with 
NAFLD [3]. Waist circumference (WC) is the most commonly 
used measure of abdominal adiposity. Although WC is a good 
general indicator of the total amount of abdominal fat, it does 
not distinguish between visceral fat and subcutaneous fat, which 
may have different relationships with metabolic diseases. NAFLD 
is associated with an increase in visceral fat and a decrease in 
subcutaneous fat even at identical WC measurements [4-9]. 
Since many studies have reported that visceral fat is a greater 
contributor to NAFLD development than subcutaneous fat, 
measurements of the amount of visceral fat in absolute terms 
or relative to subcutaneous fat have been suggested as indica-
tors of abnormal abdominal fat presence [10-14].
However, few community-based studies have examined the 
discriminatory power of these abdominal adiposity indexes 
[15], and studies that compare men and women in this regard 
are also lacking. For these reasons, we compared 3 computed 
tomography (CT)-based abdominal adiposity indexes with re-
gard to the prediction of NAFLD to determine the index with 
the best discriminatory power in a middle-aged population of 
Korean men and women.
METHODS
Study Population
The present study used baseline data from the Cardiovascu-
lar and Metabolic Diseases Etiology Research Center (CMERC) 
cohort, which consisted of community-dwelling adults aged 
30 years to 64 years in the vicinity of the capital city of Korea 
[16]. The exclusion criteria for cohort participants were diag-
nosis with cancer within the past 2 years or current treatment 
for cancer; history of myocardial infarction, stroke, or heart 
failure; current participation in any clinical drug trials; and cur-
rent pregnancy [16]. The cohort study initially enrolled 8097 
participants at 2 research clinics between 2013 and 2018. Quan-
titative computed tomography (QCT) images were available 
for only 4060 participants, because only 1 clinic of the 2 clinics 
used QCT to measure body fat distribution, while the other 
used dual-energy x-ray absorptiometry. We also excluded 214 
participants who had been diagnosed with liver cirrhosis or 
chronic hepatitis, who consumed excessive quantities of alco-
hol (>7 drink/wk for women and >14 drink/wk for men) [17], 
or for whom key variables were missing. After exclusion, 3846 
participants (1366 men and 2480 women) were eligible for 
the current analysis. 
Measurements
Patients were directly asked about health behaviors and 
personal disease history by trained interviewers using stan-
dardized questionnaires according to a predetermined proto-
col [16]. Cigarette smoking and alcohol intake status were di-
chotomized to current smokers versus past or never smokers 
and current drinkers versus past or never drinkers. Participants 
rested for at least 5 minutes in a seated position before blood 
pressure (BP) measurements were taken. Trained research per-
sonnel took BP measurements using an automated oscillo-
metric device (HEM-7080; Omron Healthcare, Kyoto, Japan). 
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
was measured 3 times each at 2-minute intervals on the right 
arm [16]. The average of the last 2 measurements was used in 
the analysis. Standing height was measured to the nearest 0.1 
cm using a stadiometer (DS-102; Dong Sahn Jenix, Seoul, Ko-
rea), and body weight was measured to the nearest 0.1 kg on 
a digital scale (DB-150; CAS, Seoul, Korea) according to the 
predetermined protocol [16]. Body mass index (BMI) was cal-
culated as the body weight divided by the standing height 
squared (kg/m2). WC was measured at the midpoint between 
the lower border of the rib cage and the iliac crest using stan-
dards recommended by the World Health Organization and 
the International Diabetes Federation [16]. Visceral fat area (VFA), 
subcutaneous fat area (SFA), and their ratio, the visceral-to-
subcutaneous fat ratio (VSR), were calculated from the QCT 
images at the level of the L4-5 intervertebral space. For these 
measurements, subjects were in the supine position, as total 
body fat volume is best predicted with the person in this posi-
tion. The QCT scan protocol included a peak kilovoltage of 120 
kVp, a current of 150 mA, a pitch of 1.0, and a slice thickness of 
3 mm (phantom model 3). Each tissue area was measured with 
an Aquarius iNtuition Viewer (version 4.4.12; TeraRecon, Foster 
City, CA, USA), which was used to determine the fat area by 
setting the attenuation values for the region of interest within 
a range of −190 Hounsfield to −30 Hounsfield units [16].
Disease Definitions 
Many diagnostic methods are used to screen for NAFLD in 
asymptomatic individuals, but no consensus exists regarding 
which is best. In the diagnosis of NAFLD, CT is known to have 
high specificity in assessing the amount of liver fat, but it has 
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relatively low sensitivity [18,19]. In this study, we used the 
NAFLD Liver Fat Score (NAFLD-LFS) because it is the most vali-
dated and reported diagnostic model available for NAFLD [20]. 
The NAFLD-LFS is a function that was developed using proton 
magnetic resonance spectroscopy in 470 Finnish patients and 
that uses predictive variables such as the presence of metabol-
ic syndrome, the presence of type 2 diabetes, and fasting se-
rum insulin, aspartate transaminase (AST), and alanine trans-
aminase (ALT) levels [21]. The formula employed after multi-
variate logistic and linear regression analyses was: NAFLD-LFS=  
−2.89+1.18×metabolic syndrome (yes=1/no=0)+0.45× 
diabetes (yes=2/no=0)+0.15×fasting insulin (mU/L)+0.04×
AST (IU/L)–0.94×AST/ALT ratio. The presence of 3 or more of 
the following criteria constituted a diagnosis of metabolic syn-
drome: WC ≥90 cm in men or ≥85 cm in women, triglycerides 
(TG) ≥150 mg/dL, high-density lipoprotein (HDL) cholesterol 
<40 mg/dL in men or <50 mg/dL in women, BP ≥130/85 mmHg 
or current antihypertensive medication use, and fasting glucose 
≥100 mg/dL or current use of an oral hypoglycemic agent or 
insulin. The optimal cut-off value for NAFLD was set at −0.640 
(sensitivity, 86%; specificity, 71%), meaning that NAFLD could 
be ruled out or diagnosed in patients who scored below and 
above that level, respectively [21]. To conduct a sensitivity anal-
ysis, we also used other NAFLD scores, such as the Fatty Liver 
Index (FLI) and the Framingham Steatosis Index (FSI), to deter-
mine the presence of NAFLD. The FLI, which is an algorithm 
based on WC, BMI, and levels of TG and gamma-glutamyl trans-
ferase, was devised using ultrasonography in 496 Italian pa-
tients. The cut-off value for NAFLD was set at 60 [22]. The FSI 
was designed based on a cross-sectional study of 1181 mem-
bers of the Framingham Third Generation Cohort, and the cut-
off value for NAFLD was set at 23 [23].
Additionally, hypertension was defined as SBP/DBP ≥140/90 
mmHg or current use of antihypertensive medication. Diabetes 
mellitus was defined as fasting plasma glucose ≥126 mg/dL, 
hemoglobin A1c ≥6.5%, or current use of an oral hypoglyce-
mic agent or insulin.
Statistical Analysis
All analyses were conducted separately for men and women 
due to the substantial sex difference with regard to body com-
position. The chi-square test, the Mantel-Haenszel chi-square 
test, and the Student t-test were used to evaluate differences 
in characteristics between people with and without NAFLD. 
The p-for trend was calculated by including an independent 
variable (quartiles) as a single continuous variable instead of 
multiple categorical variables. Multiple logistic regression mod-
els were used to evaluate the associations between the abdom-
inal adiposity indexes and NAFLD, and the results were expressed 
as odds ratios and 95% confidence intervals. Age, drinking 
status, smoking status, hypertension, diabetes mellitus, and 
BMI were adjusted for in the models in which WC was evaluat-
ed. In addition to the abovementioned variables, we addition-
ally adjusted for WC in the VFA, SFA, and VSR-evaluating mod-
els [18]. VFA, SFA, and VSR were analyzed both as continuous 
variables and quartile-based categorical variables. Lastly, we 
calculated the area under the receiver operating characteristic 
curve (AUC), the integrated discrimination improvement (IDI), 
and the net reclassification improvement (NRI) to quantify in-
cremental predictive ability when adding the indexes of VFA, 
SFA, or VSR to the models that already included WC [24]. The 
WC-based model included only WC for the assessment of ab-
dominal adiposity. Regarding NRI, we calculated both catego-
ry-based and category-free NRI. We determined the category-
based NRI by defining 2 different sets of 3 categories (<10%, 
10-20%, or >20% and <20%, 20-50%, or >50%). However, 
since the results were similar in both cases, we presented only 
1 set of NRI values based on 20% and 50% cut-offs. All analy-
ses were performed with SAS version 9.4 (SAS Institute Inc., 
Cary, NC, USA), and p-values <0.05 were considered to indi-
cate statistical significance.
Ethics Statement
The study protocol was approved by the Institutional Review 
Board of the Yonsei University College of Medicine (4-2013-
0661).
RESULTS
Table 1 presents the characteristics of the men and women 
participants depending on the presence or absence of NAFLD. 
Men with NAFLD were more likely to smoke cigarettes and to 
have hypertension and diabetes than men without the condi-
tion. In contrast, women with NAFLD were older and had a 
higher prevalence of hypertension and diabetes, but a lower 
rate of smoking and alcohol drinking than those without NAFLD. 
All 3 CT-based abdominal adiposity indexes, as well as WC, were 
higher among people with NAFLD than among those without 
the disease. Figure 1 presents correlations between WC and 
the 3 CT-based indexes for men and women separately. VFA 
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and SFA showed strong positive correlations with WC in both 
men and women (r=0.715 to 0.782; p<0.001). However, VSR 
was found to be independent of WC in men (r=0.031; p=0.252) 
and was only weakly correlated with WC in women (r=0.162; 
p<0.001). 
Table 2 and Supplemental Material 1 show the association 
between each abdominal adiposity index and NAFLD after ad-
justing for age, drinking status, smoking status, hypertension, 
diabetes mellitus, BMI, and WC. VFA and VSR were positively 
associated with NAFLD in men, while SFA was not significantly 
associated with NAFLD in men. In women, VFA and VSR were 
positively associated with NAFLD, while SFA was negatively 
associated with NAFLD. For the sensitivity analysis, we repeat-
ed the same process but replaced the LFS measurement with 
FLI or FSI. The results were quite similar to those obtained us-
ing LFS, and the data are presented in Supplemental Materials 
2 and 3.     
Table 3 summarizes numerical indicators of the extent to 
which the NAFLD risk assessment improved with the addition 
of the CT-based indexes to the WC-based model. Increases in 
AUC, IDI, category-based NRI, and category-free NRI were ob-
served when each CT-based index was added to the WC-based 
model. In men, statistically significant improvements were ob-
served in all indicators when VFA or VSR was added to the WC-
based model. However, the addition of VFA led to greater im-
provements than the addition of VSR, which was calculated 
from VFA and SFA. In women, the addition of VFA, SFA, and VSR 
each led to statistically significant improvements in all 4 indi-
Table 1. Characteristics of participants according to the presence of non-alcoholic fatty liver disease
Characteristics














   30-39 224 (24.3) 114 (25.6) 0.089 314 (14.9) 21 (5.6) <0.001
   40-49 139 (15.1) 86 (19.3) 390 (18.6) 31 (8.2)
   50-59 331 (35.9) 153 (34.4) 1018 (48.4) 214 (56.6)
   60-64 227 (24.7) 92 (20.7) 380 (18.1) 112 (29.6)
Alcohol drinking status
   Never or past drinker 139 (15.1) 57 (12.8) 0.259 685 (32.6) 143 (37.8) 0.047
   Current drinker 782 (84.9) 388 (87.2) 1417 (67.4) 235 (62.2)
Cigarette smoking status
   Never or past smoker 630 (68.4) 277 (62.2) 0.024 2037 (96.9) 374 (98.9) 0.027
   Current smoker 291 (31.6) 168 (37.8) 65 (3.1) 4 (1.1)
Hypertension
   No 673 (73.1) 213 (47.9) <0.001 1753 (83.4) 202 (53.4) <0.001
   Yes 248 (26.9) 232 (52.1) 349 (16.6) 176 (46.6)
Diabetes mellitus
   No 880 (95.5) 316 (71.0) <0.001 2045 (97.3) 252 (66.7) <0.001
   Yes 41 (4.5) 129 (29.0) 57 (2.7) 126 (33.3)
BMI (kg/m2)
   Normal (<23.0) 350 (38.0) 23 (5.2) <0.001 1170 (55.7) 60 (15.9) <0.001
   Overweight (23.0-24.9) 282 (30.6) 79 (17.7) 529 (25.2) 77 (20.4)
   Obese (≥25.0) 289 (31.4) 343 (77.1) 403 (19.2) 241 (63.8)
Abdominal adiposity index
   WC (cm) 83.8±6.5 92.9±7.0 <0.001 76.6±7.3 85.9±8.3 <0.001
   VFA (cm2) 100.6±40.0 152.1±47.2 <0.001 81.0±33.4 136.3±44.3 <0.001
   SFA (cm2) 127.2±46.5 180.0±63.4 <0.001 165.0±54.1 203.3±67.4 <0.001
   VSR 0.84±0.34 0.92±0.38 <0.001 0.51±0.20 0.73±0.31 <0.001
Values are presented as number (%) or mean±standard deviation. 
NAFLD, non-alcoholic fatty liver disease; BMI, body mass index; WC, waist circumference; VFA, visceral fat area; SFA, subcutaneous fat area; VSR, visceral-to-
subcutaneous fat ratio.
















































Pearson correlation coefficient: 0.767 (p<0.001)
WomenMen
Figure 1. Correlation between WC and computed tomography-based indexes (VFA: A and B; SFA: C and D; VSR: E and F) of ab-






















Pearson correlation coefficient: 0.162 (p<0.001)
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Table 2. Association between computed tomography-based abdominal adiposity indexes and NAFLD
Abdominal adiposity 
index
Men (n=1366) Women (n=2480)
Range n n (%) of NAFLD
OR 
(95% CI)1 Range n 





   Q1 <82.3 341 15 (4.4) 1.00 (reference) <59.6 620 6 (1.0) 1.00 (reference)
   Q2 82.3-111.8 342 67 (19.6) 2.59 (1.36, 4.95) 59.6-83.3 620 28 (4.5) 2.99 (1.19, 7.51)
   Q3 111.9-146.4 340 141 (41.5) 4.73 (2.45, 9.16) 83.4-110.0 620 78 (12.6) 6.65 (2.72, 16.23)
   Q4 ≥146.5 343 222 (64.7) 6.14 (2.96, 12.73) ≥110.1 620 266 (42.9) 17.84 (7.12, 44.71)
   p for trend <0.001 <0.001
   continuous (per 10 cm2) 1.13 (1.07, 1.18) 1.26 (1.20, 1.32)
SFA 
   Q1 <105.2 341 28 (8.2) 1.00 (reference) <131.4 620 44 (7.1) 1.00 (reference)
   Q2 105.2-135.9 342 78 (22.8) 1.37 (0.79, 2.38) 131.4-164.3 620 66 (10.7) 0.54 (0.34, 0.88)
   Q3 136.0-174.9 341 139 (40.8) 1.66 (0.93, 2.97) 164.4-203.9 620 108 (17.4) 0.50 (0.31, 0.81)
   Q4 ≥175.0 342 200 (58.5) 1.26 (0.64, 2.48) ≥204.0 620 160 (25.8) 0.21 (0.12, 0.38)
   p for trend    0.592 <0.001
   continuous (per 10 cm2) 0.99 (0.94, 1.04) 0.89 (0.86, 0.92)
VSR
   Q1 <0.61 341 98 (28.7) 1.00 (reference) <0.39 620 33 (5.3) 1.00 (reference)
   Q2 0.61-0.79 342 103 (30.1) 1.39 (0.88, 2.20) 0.39-0.48 620 53 (8.6) 1.39 (0.81, 2.38)
   Q3 0.80-1.03 341 115 (33.7) 1.91 (1.20, 3.03) 0.49-0.64 620 88 (14.2) 3.06 (1.83, 5.12)
   Q4 ≥1.04 342 129 (37.7) 1.99 (1.22, 3.26) ≥0.65 620 204 (32.9) 6.73 (4.10, 11.03)
   p for trend    0.003 <0.001
   continuous (per 0.1 SD) 1.03 (1.01, 1.05) 1.07 (1.06, 1.09)
NAFLD, non-alcoholic fatty liver disease; OR, odds ratio; CI, confidence interval; VFA, visceral fat area; SFA, subcutaneous fat area; VSR, visceral-to-subcutane-
ous fat ratio.
1Adjusted for age, drinking status, smoking status, hypertension, diabetes mellitus, body mass index, and waist circumference.
Table 3. Comparison of discriminatory power of abdominal adiposity indexes in the detection of NAFLD
Abdominal adiposity 
index
AUC Improved AUC IDI Category-based NRI1 Category-free NRI
Index Index p-value Index p-value Index p-value Index p-value
Men
   Base model2 0.813
   WC3 0.842 Reference Reference Reference Reference
   WC+VFA 0.855 0.013 <0.001 0.024 <0.001 0.050 0.018 0.296 <0.001
   WC+SFA 0.843 0.001 0.434 0.002 0.160 △0.002 0.835 0.074 0.201
   WC+VSR 0.851 0.009 0.007 0.017 <0.001 0.050 0.012 0.262 <0.001
Women
   Base model2 0.807
   WC3 0.818 Reference Reference Reference Reference
   WC+VFA 0.862 0.044 <0.001 0.075 <0.001 0.181 <0.001 0.620 <0.001
   WC+SFA 0.836 0.017 <0.001 0.040 <0.001 0.113 <0.001 0.412 <0.001
   WC+VSR 0.865 0.046 <0.001 0.089 <0.001 0.207 <0.001 0.654 <0.001
NAFLD, non-alcoholic fatty liver disease; AUC, area under the receiver operating characteristic curve; IDI, integrated discrimination improvement; NRI, net re-
classification improvement; WC, waist circumference; VFA, visceral fat area; SFA, subcutaneous fat area; VSR, visceral-to-subcutaneous fat ratio; △, negative 
number.
1For the category-based NRI, risk cut-offs of 20% and 50% were used.
2The base model is adjusted for age and body mass index.
3The WC-based model is adjusted for age, body mass index, and WC.
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cators. However, the addition of VSR led to greater improve-
ments than that of either VFA and SFA.
To visualize the changes that occurred upon addition of the 
CT indexes, we drew scatter plots of estimated NAFLD proba-
bility in the CT index-added models versus the WC-based 
model. We did this separately in the NAFLD-present and the 
NAFLD-absent groups (Supplemental Material 4). In men, the 
addition of the SFA index made little change to the NAFLD 
probabilities in both groups. On the contrary, the addition of 
VFA or VSR resulted in a higher probability of NAFLD diagnosis 
(indicated by dots above the diagonal line) for some partici-
pants in the NAFLD-present group. In women, the addition of 
all 3 CT indexes led to higher probabilities (indicated by dots 
above the diagonal line) of NAFLD diagnosis in the NAFLD-
present group and lower probabilities (indicated by dots be-
low the diagonal line) of diagnosis in the NAFLD-absent group 
(Supplemental Material 4).
As a further analysis, we assessed the NAFLD predictive ca-
pacity of the CT-based abdominal adiposity indexes in 3 sepa-
rate groups that were divided by BMI, an index of general 
obesity. In men, the CT-based indexes produced significant 
improvements in the overweight (BMI 23.0-24.9 kg/m2) and 
obese (BMI ≥25.0 kg/m2) groups, but not in the normal-BMI 
group (<23.0 kg/m2). However, in women, the addition of the 
CT-based indexes resulted in significant improvements to all 
BMI groups, with data presented in Supplemental Material 5.
DISCUSSION
In this study of healthy middle-aged men and women, the 
addition of a CT-based abdominal adiposity index was found 
to better distinguish the probable presence of NAFLD than the 
use of WC alone. Among the 3 CT-based indexes studied, VFA 
and VSR, when added to the model, showed the best im-
proved discriminatory power in men and women, respectively.
Previous studies have evaluated the associations of the ab-
solute or relative amounts of visceral and subcutaneous fat 
with NAFLD. A 4-year follow-up study of a total of 2017 adults 
reported that a larger amount of visceral fat was longitudinally 
associated with a higher risk of incident NAFLD, and a larger 
amount of subcutaneous fat was longitudinally associated 
with the regression of NAFLD [4]. In another cross-sectional 
study of 408 adults, a larger amount of femoral subcutaneous 
fat was negatively associated with NAFLD in women, but not 
in men [25]. 
VSR can be a useful index to identify individuals at risk of 
cardiovascular disease [7,8] and metabolic syndrome [15]. 
Higher VSR, as assessed by a dual bioelectrical impedance an-
alyzer, has been found to be associated with cardiovascular 
events in patients with type 2 diabetes who regularly visited 
the university hospital in Tokyo, Japan [7]. In a cross-sectional 
study of 535 adults, VSR showed superior AUC values in pre-
dicting at least 2 non-adipose factors for metabolic syndrome 
(hyperglycemia, high BP, high TG, and low HDL cholesterol) in 
men with a normal WC [15]. In the present study, we com-
pared the NAFLD predictive value of CT-based abdominal adi-
posity indexes and used not only AUC, but also IDI and NRI for 
the comparison of the discriminatory power.
In this study, as shown in Table 2, the results varied not only 
by type of fat, but also by gender. In women, subcutaneous fat 
was found to be negatively associated with NAFLD. In men, 
however, subcutaneous fat was not associated with NAFLD. 
Previous studies have shown differences between visceral and 
subcutaneous fat with regard to the associated pathologies 
and physiologies [3,26]. Venous drainage from subcutaneous 
fat is directed into the systemic circulation, whereas venous 
drainage from visceral fat is routed into the portal vein. Thus, 
the metabolic products of visceral fat reach the liver directly 
and exercise a first-pass effect on liver metabolism. It has been 
hypothesized that visceral fat releases free fatty acids and adi-
pokines and thereby exposes the liver to fat accumulation [3-
5,10,13,21], whereas subcutaneous fat could act as a possible 
‘metabolic sink’ for metabolic diseases, including NAFLD [4]. 
Additionally, the type and function of fat deposits differ by 
gender. Men tend to store more visceral fat, whereas women 
are more likely to store subcutaneous fat before menopause 
and visceral fat after menopause. It is well recognized that sex 
hormones contribute to this regulation [27]. Estrogen plays an 
important role in regulating metabolism and lipogenesis [8]. 
In this study, the role of subcutaneous fat as a metabolic sink 
appeared to be different in men and women. In order to ana-
lyze visceral fat and subcutaneous fat separately as mentioned 
above, image-based indicators should be used in future stud-
ies. This will facilitate the creation of a composite abdominal 
adiposity index, such as VSR.
The mechanisms governing body fat distribution remain 
largely unknown, although age, gender, stress, smoking, a lack 
of physical activity, and endocrine and genetic factors have 
been shown to have a significant impact  [9,11,21,28-30]. Fat 
distribution could therefore be interpreted as a marker that 
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explain the physiological status of the human body. The lipid 
overflow ectopic fat model suggests that surplus energy is 
physiologically stored primarily in subcutaneous fat, which 
acts as a metabolic sink for circulating non-esterified fatty ac-
ids. However, when this depot is dysfunctional, energy can al-
ternatively be deposited in visceral fat [6]. The failure of adipo-
cyte proliferation and differentiation has been discussed as a 
possible mechanism of functional subcutaneous fat insuffi-
ciency. The relatively greater quantity of visceral fat may then 
cause hepatic insulin resistance by releasing a variety of bio-
logically active molecules, such as non-esterified fatty acids 
and inflammatory mediators, into the portal vein system (the 
‘portal vein hypothesis’), resulting in NAFLD [6]. In this study, 
VSR, which could be interpreted as relative body fat distribu-
tion, was found to be positively associated with NAFLD in men 
and women. VSR was nearly independent of WC and was as-
sociated with different findings than the absolute measures of 
fat, such as VFA and SFA, as shown in Figure 1.
In women, VSR was shown to be a better predictor of NAFLD 
than VFA. Because SFA was not associated with NAFLD and 
had no role as a metabolic sink in men, the relative distribu-
tion of VFA and SFA had no specific meaning. Thus, it can be 
concluded that VFA is more important than VSR in men. How-
ever, in women, the opposite associations of VFA and SFA with 
NAFLD were found. Thus, VSR, which indicates one’s personal 
pattern of fat distribution, may be more meaningful than the 
absolute amount of fat in the discrimination of NAFLD in 
women. The strength of association and the discriminatory 
power were different parts in understanding the relationships 
between abdominal adiposity indexes and NAFLD.
In the current study, improvements in discrimination as as-
sessed through IDI and NRI were evident, but the increase in 
the AUC was relatively small. As in many other studies, the use 
of the AUC was limited because this measure is not sensitive 
to model comparisons if the reference model performs well, 
particularly if it is greater than 0.8.
In men, VFA was the abdominal adiposity index that was the 
best predictor of NAFLD in all BMI subgroups. In contrast, a 
difference was observed in the BMI subgroups among wom-
en. In women with normal BMI, the addition of VFA conferred 
the greatest improvement in AUC. However, in overweight 
and obese women, the addition of VSR led to the greatest im-
provement in AUC. As mentioned regarding the hypothesis 
that subcutaneous fat has an opposite association with 
NAFLD, it could be interpreted that VSR would be meaningful 
only if one assumes that a certain amount of subcutaneous fat 
acting as a metabolic sink is present. However, further studies 
are needed.
The current study had some limitations. First, we could not 
confirm the presence or absence of NAFLD via liver pathology, 
which is considered the gold standard for NAFLD diagnosis. 
Liver biopsy is almost impossible to use for screening for liver 
diseases in asymptomatic individuals, so most epidemiologi-
cal studies use imaging or biochemical tests to assess the 
presence of NAFLD. Thus, we used NAFLD-LFS, a common 
composite variable of determining NAFLD, and applied other 
2 methods as a sensitivity analysis. The positive and negative 
predictive values of LFS must be studied further in the Korean 
population. Second, the participants were middle-aged adults 
residing in the area of Korea’s capital; therefore, these results 
cannot be generalized to the entire Korean adult population. 
Third, this study was cross-sectional in nature, so we could 
only predict the probability of currently having NAFLD and 
could not determine whether abdominal adiposity indexes 
can predict the onset or progression of NAFLD. 
The results of the current study suggest that measuring the 
absolute or relative amounts of visceral and subcutaneous fat 
in the abdomen, using CT images, can aid in the detection of 
individuals with probable fatty liver disease. Among the 3 in-
dexes studied, VFA and VSR yielded the greatest improvement 
in discriminatory power when added to the WC-based model 
in men and women, respectively.
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